Accelerated Treatment for Co-occurring Insomnia, Nightmares, and PTSD (NCT07069517) | Clinical Trial Compass
RecruitingNot Applicable
Accelerated Treatment for Co-occurring Insomnia, Nightmares, and PTSD
United States160 participantsStarted 2025-12-02
Plain-language summary
This study is a two-arm individually randomized group treatment clinical trial evaluating behavioral therapies for insomnia, nightmares, and PTSD. The study will compare cognitive-behavioral therapy for insomnia and nightmares to sleep hygiene (Control), both integrated with Written Exposure Therapy for PTSD and delivered in an accelerated (i.e., 5-day) group treatment format, preceded and followed by individual treatment sessions. 160 participants will be randomized into one of two study conditions.
Who can participate
Age range18 Years β 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
β. Defense Enrollment Eligibility Reporting System (DEERS) eligible active-duty military personnel or veteran, 18-65 years old.
β. Ability to speak and read English.
β. Clinically significant PTSD symptoms (CAPS-5 \> 25 with at least one Intrusion symptom and at least one Avoidance symptom).
β. Clinically significant symptoms of insomnia disorder (Structured Clinical Interview for Sleep Disturbance DSM-5 (SCISD) Insomnia Criteria are met and Insomnia Severity Index (ISI) \> 11).
β. Nightmares \> 1 monthly (as reported on the SCISD).
β. Willing to refrain from new behavioral health or medication treatment for issues pertaining to PTSD, sleep, and nightmares during study participation.
Exclusion criteria
β. Current suicide or homicide risk meriting crisis intervention.
β. Inability to comprehend the baseline screening questionnaires.
β. Unwilling to remain abstinent from alcohol during therapy sessions.
β. Serious mental health symptoms, such as mania, psychosis, alcohol or substance use disorders warranting immediate clinical attention based on interviewer assessment and clinical judgement.
β. Currently engaged in evidence-based psychotherapy for PTSD (e.g., Prolonged Exposure Therapy, Cognitive Processing Therapy, Written Exposure Therapy) or insomnia or nightmares (e.g., Cognitive Behavioral Therapy for Insomnia or Nightmares).
What they're measuring
1
Posttraumatic Stress Disorder Checklist (PCL-5)
Timeframe: Change from baseline through 3 and 6 month follow-up assessment
2
Insomnia Severity Index (ISI)
Timeframe: Change from baseline through 3 and 6 month follow up
3
Nightmare Disorders Index
Timeframe: Change from baseline through 3 and 6 month assessments